Edition:
United States

Aratana Therapeutics Inc (PETX.OQ)

PETX.OQ on NASDAQ Stock Exchange Global Market

6.39USD
20 Nov 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$6.39
Open
$6.43
Day's High
$6.43
Day's Low
$6.23
Volume
89,882
Avg. Vol
77,995
52-wk High
$7.28
52-wk Low
$3.68

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.09 December 21 Nov 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 3 3 3 4
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.60 1.60 1.60 1.67

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 5 9.05 20.20 5.25 15.81
Quarter Ending Mar-19 5 9.72 11.22 8.00 16.39
Year Ending Dec-18 3 36.33 36.98 35.10 37.42
Year Ending Dec-19 5 47.08 53.20 44.40 71.36
Earnings (per share)
Quarter Ending Dec-18 4 -0.09 -0.01 -0.14 -0.01
Quarter Ending Mar-19 3 -0.13 -0.07 -0.19 -0.08
Year Ending Dec-18 5 -0.40 -0.25 -0.61 -0.45
Year Ending Dec-19 5 -0.25 -0.10 -0.42 0.01

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 5.61 6.55 0.94 16.82
Quarter Ending Jun-18 5.06 4.91 0.15 2.99
Quarter Ending Mar-18 5.28 4.04 1.23 23.39
Quarter Ending Dec-17 6.82 10.46 3.64 53.33
Quarter Ending Sep-17 6.47 6.16 0.31 4.75

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 9.05 9.05 16.13 16.13 15.81
Quarter Ending Mar-19 9.72 9.72 9.16 9.16 16.39
Year Ending Dec-18 36.33 36.33 29.89 29.89 37.42
Year Ending Dec-19 47.08 47.08 46.18 46.18 71.36

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 0 0 0 4
Quarter Ending Mar-19 0 0 1 2
Year Ending Dec-18 0 0 2 0
Year Ending Dec-19 0 0 1 2
Earnings